New Hemophilia Clotting Factor and HCPCS Code
Effective for claims with dates of service on or after April 1, 2008, Health Care Procedure Code System (HCPCS) code Q4096 (Injection, Von Willebrand Factor Complex, Human, Ristocetin Cofactor) will be payable for Medicare. Appropriate systems changes for editing hemophilia clotting factors on inpatient claims will be made by FISS in the January 2009 release. This factor is payable on outpatient claims effective April 1, 2008.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 25, 2008
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.